Stock research
NBTX Nanobiotix S.A.
Healthcare • Biotechnology
Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising...…
Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma, various head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has established a strategic collaboration with LianBio for the development and commercialization of NBTXR3 within key Asian markets, specifically Greater China, South Korea, Singapore, and Thailand. Founded in 2003, the company's main operations are situated in Paris, France.
1Y change
+500.30%
Range high
$55.07
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in NBTX?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $37.85
- Day High
- $40.47
- Day Low
- $38.22
- 52w High
- $57.14
- 52w Low
- $6.09
- Volume
- 150,488
- Avg Volume
- Beta
- 0.56
* TTM/most recent where available
Company
- Ticker
- NBTX
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- FR
- CEO
- Laurent Levy
- Employees
- 100
- Website
- www.nanobiotix.com
Key Metrics
- Market Cap
- 2.03B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).